David Shaw’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,800
Closed -$531K 4653
2025
Q3
$531K Buy
+18,800
New +$539K ﹤0.01% 3839
2016
Q1
Sell
-3,100
Closed -$276K 3467
2015
Q4
$276K Hold
3,100
﹤0.01% 3418
2015
Q3
$281K Buy
+3,100
New +$311K ﹤0.01% 3372
2013
Q4
Sell
-40,000
Closed -$3.04M 4482
2013
Q3
$3.04M Hold
40,000
﹤0.01% 2054
2013
Q2
$2.96M Buy
+40,000
New +$2.68M 0.01% 1757

Other funds holding CRI

David Shaw's CRI Position: Q2 2026 in Review

David Shaw reduced its Carter's (CRI) stake by 45% in Q2 2026, selling an estimated $9.92M and leaving 322,420 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #1599.

David Shaw first reported a position in CRI in Q2 2013 and has held it in 41 quarters since. The position peaked at $68.1M in Q2 2016. 285 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • David Shaw held 322,420 shares of Carter's worth $13.3M as of Q2 2026.
  • David Shaw sold 262,204 Carter's shares in Q2 2026, an estimated $9.92M.
  • Carter's made up 0.01% of David Shaw's portfolio in Q2 2026, its #1599 holding.
  • David Shaw first reported a position in Carter's in Q2 2013 and has held it in 41 quarters since.
  • David Shaw's Carter's position peaked at $68.1M in Q2 2016.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.